Effects of ipragliflozin on glycemic control, appetite and its related hormones: A prospective, multicenter, open‐label study (SOAR‐KOBE Study)

AIMS/INTRODUCTION: Sodium–glucose cotransporter 2 (SGLT‐2) inhibitors improve blood glucose control, as well as reducing bodyweight by promoting urinary glucose excretion. The weight loss is less than expected from urinary glucose loss, however, likely because of an increase in food intake. To inves...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Diabetes Investig
Main Authors: Miura, Hiroshi, Sakaguchi, Kazuhiko, Okada, Yuko, Yamada, Tomoko, Otowa‐Suematsu, Natsu, So, Anna, Komada, Hisako, Hirota, Yushi, Ohara, Takeshi, Kuroki, Yasuo, Hara, Kenta, Matsuda, Tomokazu, Kishi, Minoru, Takeda, Akihiko, Yokota, Kazuki, Tamori, Yoshikazu, Ogawa, Wataru
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2019
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717805/
https://ncbi.nlm.nih.gov/pubmed/30688412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13015
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker